NASDAQ$UAL

United Airlines Holdings Inc · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

United Airlines announced second quarter 2020 financial results, which were heavily impacted by the COVID-19 pandemic.

United Airlines reported a net loss of $1.6 billion and an adjusted net loss of $2.6 billion for the second quarter of 2020. Total operating revenues decreased by 87.1% year-over-year due to an 87.8% decrease in capacity. The company took aggressive actions to mitigate the impact of COVID-19 by raising liquidity and reducing cash burn, ending the quarter with $15.2 billion in liquidity.

  • United Airlines reported a net loss of $1.6 billion in Q2 2020.
  • Total operating revenues decreased 87.1% year-over-year.
  • The company raised $16.1 billion through debt offerings, stock issuances, and the CARES Act.
  • United expects Q3 capacity to be down 65% compared to Q3 2019.

Headline financials

Total Revenue

$1.48B

Previous: $11.4B-87.1%
EPS (adj)

-$9.31

Previous: $4.21-321.1%
PRASM

7.6

Previous: 14.32-46.9%
CASM

34.72

No prior period
Load Factor

33.1%

Previous: 86.0%-61.5%
Passenger Yield

22.93

Previous: 16.64+37.8%
ASMs

9.0B

No prior period
RPMs

3.0B

No prior period
Stage Length

1.1K

No prior period
Free Cash Flow

-$1.63B

Previous: $1.05B-254.7%
Net Income

-$1.63B

Previous: $1.05B-254.7%
Operating Income

-$1.64B

Previous: $1.47B-211.2%
Gross Profit

-$716M

Previous: -$3.11B+77.0%
Cash & Equivalents

$6.51B

Previous: $3.22B+102.0%
Total Assets

$54.9B

Previous: $52.2B+5.3%

Revenue & EPS history

United Airlines · Revenue · Quarterly

$1.48B

Q2 2020-87.1%vs Q2 2019
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

United Airlines · $1.48B total across 3 segments · Q2 2020

  • Passenger
    $681M
  • Cargo
    $402M+36.3%
  • Other Operating
    $392M-36.9%

Forward guidance

The company expects consolidated system capacity to be down 65% in Q3 2020 versus Q3 2019 and will continue to proactively evaluate and cancel flights on a rolling 60-day basis until it sees signs of a recovery in demand. Demand is expected to remain suppressed until the availability of a widely accepted treatment and/or vaccine for COVID-19.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

-0.5%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+3.4%

Avg return

30 days after

48%

33 / 69 earnings

Positive

+18.8%

Q1 2024

Best reaction

-15.4%

Q2 2010

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.7%-5.4%+3.0%
Q4 2025-1.2%-0.7%+4.1%
Q3 2025-5.8%-3.8%-8.7%
Q2 2025+1.8%+0.7%+7.5%
Q1 2025-0.0%-2.5%+16.3%
Q4 2024+0.5%-2.2%-4.6%
Q3 2024+13.4%+16.7%+43.5%
Q2 2024-1.4%+2.4%-10.6%
Q1 2024+18.8%+25.2%+33.5%
Q4 2023+4.3%+9.6%+13.5%
Q3 2023-8.3%-11.2%-0.6%
Q2 2023+3.2%+2.3%-10.4%
Q1 2023+9.2%+4.9%+13.6%
Q4 2022-5.4%-4.2%-5.2%
Q3 2022+8.3%+12.0%+19.8%
Q2 2022-9.7%-12.4%-9.6%
Q1 2022+10.7%+11.6%-5.2%
Q4 2021-6.0%-9.3%+4.0%
Q3 2021-2.6%-0.9%+0.6%
Q2 2021+10.7%+9.4%+1.1%
Q1 2021-10.0%-4.9%-0.1%
Q4 2020-4.8%-9.8%+7.3%
Q3 2020-2.9%+0.7%+10.6%
Q2 2020-2.0%+1.7%+5.3%
Q1 2020-14.7%-22.7%-10.2%
Q4 2019-7.1%-8.7%-10.9%
Q3 2019+3.1%+3.6%+6.4%
Q2 2019+3.8%+2.7%-10.6%
Q1 2019+5.6%+4.4%-2.3%
Q4 2018+8.1%-3.2%+8.6%
Q3 2018+8.8%+7.5%+13.1%
Q2 2018+9.3%+12.0%+13.3%
Q1 2018+4.9%+6.6%+3.2%
Q4 2017-10.2%+14.4%-7.5%
Q3 2017-11.5%-12.5%-13.8%
Q2 2017-6.9%-10.3%-18.9%
Q1 2017-1.9%+0.7%+10.3%
Q4 2016-0.4%+4.3%+2.4%
Q3 2016+0.9%+4.5%+23.1%
Q2 2016+1.2%-0.3%-0.2%
Q1 2016-9.1%
Q4 2015+3.5%
Q3 2015+9.4%
Q2 2015-1.0%
Q1 2015-0.8%
Q4 2014+5.6%
Q3 2014+1.1%
Q2 2014+1.7%
Q1 2014-14.4%
Q4 2013-6.2%
Q3 2013+0.7%
Q2 2013+3.7%
Q1 2013-0.8%
Q4 2012+2.0%
Q3 2012-5.2%
Q2 2012-6.6%
Q1 2012-3.5%
Q4 2011-2.8%
Q4 2008-2.8%
Q3 2011-4.6%
Q4 2010-4.6%
Q2 2011-4.6%
Q1 2010+4.8%
Q1 2011-3.8%
Q2 2010-15.4%
Q3 2009+0.3%
Q3 2010+0.3%
Q2 2009+2.8%
Q4 2009+2.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro